ImmunoForge
Operator of a drug development and pharmaceutical company intended to develop drugs for treating sarcopenia and cancer. The company's drugs specialize in targeting Duchenne muscular dystrophy, ALS, se...
Valuation
$0
Share Price
N/A
Total Raised
$27.8M
Last Round
N/A